Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
Kawada T, Yanagisawa T, Rajwa P, Motlagh RS, Mostafaei H, Quhal F, Laukhtina E, Pallauf M, König F, Pradere B, Araki M, Nasu Y, Shariat SF. Kawada T, et al. Among authors: pallauf m. Clin Genitourin Cancer. 2024 Apr;22(2):535-543.e4. doi: 10.1016/j.clgc.2024.01.008. Epub 2024 Jan 17. Clin Genitourin Cancer. 2024. PMID: 38336572 Free article. Review.
Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function.
Hensley PJ, Labbate C, Zganjar A, Howard J, Huelster H, Durdin T, Pham J, Xiao L, Pallauf M, Lombardo K, Glezerman I, Singla N, Raman JD, Coleman J, Spiess PE, Margulis V, Potretzke AM, Matin SF. Hensley PJ, et al. Among authors: pallauf m. Eur Urol Oncol. 2024 Feb 1:S2588-9311(24)00030-0. doi: 10.1016/j.euo.2024.01.005. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38307832
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
Fletcher SA, Pallauf M, Watts EK, Lombardo KA, Campbell JA, Rezaee ME, Rouprêt M, Boorjian SA, Potretzke AM, Roshandel MR, Ploussard G, Djaladat H, Ghoreifi A, Mari A, Campi R, Khene ZE, Raman JD, Kikuchi E, Rink M, Abdollah F, Boormans JL, Fujita K, D'Andrea D, Soria F, Breda A, Hoffman-Censits J, McConkey DJ, Shariat SF, Pradere B, Singla N. Fletcher SA, et al. Among authors: pallauf m. Eur Urol Oncol. 2024 Jan 22:S2588-9311(24)00035-X. doi: 10.1016/j.euo.2024.01.010. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38262800
Reply by Authors.
Rezaee ME, Pallauf M, Fletcher SA, Han M, Pavlovich CP, Cornelia Ding CK, Epstein JI, Allaf ME, Trock BJ, Singla N. Rezaee ME, et al. Among authors: pallauf m. J Urol. 2024 Mar;211(3):413-414. doi: 10.1097/JU.0000000000003825.02. Epub 2024 Jan 10. J Urol. 2024. PMID: 38198586 No abstract available.
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
Rajwa P, Quhal F, D'Andrea D, Korn S, Petrov P, Yanagisawa T, Kawada T, Motlagh RS, Mostafaei H, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Nyirády P, Abufaraj M, Marra G, Gandaglia G, Briganti A, Karakiewicz P, Ye DW, Haydter M, Chlosta P, Comperat E, Enikeev D, Shariat SF. Rajwa P, et al. Among authors: pallauf m. Arab J Urol. 2023 Apr 3;21(4):241-247. doi: 10.1080/2090598X.2023.2196911. eCollection 2023. Arab J Urol. 2023. PMID: 38178943 Free PMC article.
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis.
Majdoub M, Yanagisawa T, Quhal F, Laukhtina E, von Deimling M, Kawada T, Rajwa P, Bianchi A, Pallauf M, Mostafaei H, Chlosta M, Pradere B, Karakiewicz PI, Schmidinger M, Rub R, Shariat SF. Majdoub M, et al. Among authors: pallauf m. Int J Cancer. 2024 Apr 1;154(7):1309-1323. doi: 10.1002/ijc.34793. Epub 2023 Nov 27. Int J Cancer. 2024. PMID: 38009868
66 results